Moderna’s updated COVID vaccine appears to generate “a strong human immune response against the highly mutated BA.2.86 variant,” the company said Wednesday, citing new clinical trial data.
Related Keywords
Stephen Hoge ,Drug Administration ,Centers For Disease ,Disease Control ,Public Service News , ,
comparemela.com © 2020. All Rights Reserved.